Preliminary Clinical Activity Of Rmc-6236, A First-In-Class, Ras-Selective, Tri-Complex Ras-Multi(On) Inhibitor In Patients With Kras Mutant Pancreatic Ductal Adenocarcinoma (Pdac) And Non-Small Cell Lung Cancer (Nsclc)
RMC-6236
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: Preliminary Clinical Activity Of Rmc-6236, A First-In-Class, Ras-Selective, Tri-Complex Ras-Multi(On) Inhibitor In Patients With Kras Mutant Pancreatic Ductal Adenocarcinoma (Pdac) And Non-Small Cell Lung Cancer (Nsclc) ### Output: RMC-6236